NOW AVAILABLE: For the European NSCLC Market – A SnapShot analysis of promotional messaging and DTC initiatives for Q3, 2016.

The European NSCLC market produced 50 pieces during Q3 and its promotional distribution was dominated by Nivolumab BMS/Opdivo, which single handedly acquired 34% of the market’s total volume. Nivolumab BMS continued its transition to Opdivo with pieces from France, Germany, Italy, and the UK, featuring the new trade name. In addition, Portrazza introduced a new campaign theme with the “Mosaic Lungs” imagery. Additional insights into marketing strategies and channel utilization are available in the full Q3 report.

Ex-US-2016-Q3-NSCLC

About SnapShot

Helping to keep abreast of key competitor’s marketing strategies, CD Promo SnapShot is a quarterly competitive intelligence service of dtw Research, Inc. Snapshot reports provide an analytical view into the messaging and marketing tactics within specific therapeutic areas. The reports are sourced from dtw’s CD Promo WorldWide, the digitalized database of virtually all promotional materials distributed by the pharmaceutical industry since 1996. SnapShot reports include a detailed analysis of each brand’s messaging evolution, physician and DTC campaign initiatives, efficacy/comparative data, dosing, patient access, education and support programs, and more.

Reports are available by annual subscription for over 50 primary and specialty markets.

For more information please contact:

US Markets: Christine Alongi at Alongi@dtwresearch.com

Ex-US Markets: Robin Cefalo at Cefalo@dtwresearch.com